GlassScriptPhysician profile
Ian Nguyen
NPI 1144489691
$924.18
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2022: $221 · 2023: $297 · 2024: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $212.06 | 2022-2024 | Veozah |
| Amgen INC. | $121.87 | 2022 | |
| Intuitive Surgical, INC. | $100.00 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $78.73 | 2019 | |
| Pfizer INC. | $50.26 | 2023 | |
| Abiomed | $50.19 | 2024 | Impella |
| Coopersurgical, INC. | $43.18 | 2022-2023 | Paragard T 380a |
| Ethicon US, LLC | $40.00 | 2019 | |
| Evofem Biosciences, INC. | $31.47 | 2022-2023 | Phexxi |
| Millicent US INC | $28.36 | 2019-2023 | Intrarosa, Femring |
| Organon LLC | $27.43 | 2024 | |
| Emd Serono, INC. | $27.21 | 2024 | |
| Sage Therapeutics, LLC | $26.59 | 2024 | |
| Medicem INC. | $23.40 | 2022 | |
| Agile Therapeutics, INC. | $16.69 | 2023 | Twirla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.40 | 2023 | Gardasil 9 |
| Mylan Pharmaceuticals INC. | $15.63 | 2022 | |
| Avion Pharmaceuticals | $14.71 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.